| Autor: |
Mirela Anghelina, Michelle J. Naughton, Qiuhong Zhao, Amy S. Ruppert, Jasmine Neal, Kerry A. Rogers, James S. Blachly, Gerard Lozanski, Seema A. Bhat, Eric Kraut, Narendranath Epperla, Puneet Mathur, Clive S. Zent, Versha Banerji, Claire Dearden, Terri Hutchinson, Michael Grever, Leslie A. Andritsos |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Leukemia Research. 120:106919 |
| ISSN: |
0145-2126 |
| Popis: |
A diagnosis of leukemia can have a profound effect on patients' health-related quality of life (HRQoL), however this has not been measured prospectively in patients with hairy cell leukemia (HCL). At the request of patients living with HCL who had identified this gap in knowledge about the disease, we conducted a longitudinal study of HRQoL among patients enrolled in the HCL Patient Data Registry (PDR). From September 1, 2018 to September 1, 2020, 165 patients were enrolled in the study and completed the baseline survey. The Functional Assessment of Cancer Therapy - Leukemia (FACT-Leu) was used to measure patients' HRQoL. Results show that newly diagnosed HCL patients reported the lowest HRQoL, followed by patients in relapse and those on "watch and wait." Factors associated with higher (better) FACT-Leu total scores in the multivariable analysis included older age, higher social support, and greater physical activity. These same factors were associated with lower levels of fatigue. In rare diseases where it is difficult to perform large prospective studies, patient/researcher collaborations are critical for the identification of studies that are of importance to patients and their families in order to maximize the benefits of the research and improve the lives of patients living with HCL. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect